Blood-Brain Barrier Technologies and Global Markets

26-Aug-2011 | News-Press Release

Bharatbook added a new report on "Blood-Brain Barrier Technologies and Global Markets" which gives the in-depth analysis and forecast on Blood-Brain Barrier Technologies and Global Markets

The global market for blood-brain barrier (BBB) technology for therapeutics amounted to $12.3 million in 2010 and will reach $387 million by 2015, a compound annual growth rate (CAGR) of 99.3%.

The most common means of BBB passage or type of technology will be receptor-mediated transport (RMT), meaning crossing the BBB via certain receptors that include the insulin or transferrin receptors. This technology was valued at $12 million in 2010 and is expected to increase at a nearly 99% compound annual growth rate (CAGR) to reach $376 million in 2015.

The other technology to emerge as a vehicle for taking a drug across the BBB that otherwise could not cross it is carrier-mediated transport. This sector was valued at $0.2 million in 2010 and is expected to increase at a 121% compound annual growth rate (CAGR) to reach $10.5 million in 2015.



BCC’s goal in conducting this study was to determine the current status of the global therapeutic market for blood-brain barrier (BBB) technologies, including its growth potential over a 5-year period from 2010 to 2015. Our key objective was to present a comprehensive analysis of the current BBB technology and drug development market and its future direction with the aim to first define and classify that technology as it pertains to therapeutics in which the technology enables the therapeutic to directly cross rather than bypass the BBB.(


BBB technologies are going to open up a vast untapped potential in the growing central nervous system therapeutic market where today growth is limited by the complexity of this layer in the brain that prevents the passage of many potentially useful molecules/compounds.

This report offers a picture of this technology potential that is on the verge of rapid increase. Therapeutics make up the main area of investment related to this technology; and, therefore, that is this report’s focus. BCC has not yet examined the BBB, although the central nervous system has been a consistent focus. As such, this snapshot and study of trending and growth is unique.


The scope of this study encompasses companies that develop technologies to enable the crossing of the BBB and drug development in which a quality of the development is enabling the crossing of the BBB in cases in which passage was previously impossible often due to size. BCC analyzes each technology, determines its current market status, examines its impact on future markets, and presents forecasts of growth over the next 5 years. Technological issues, including the latest trends, are discussed.


In the report, BBB technology is described in terms of what it is and its history in medicine, the types and technology categories, major companies, impact on the pharmaceutical market, applications, current market values, growth potential, and significant trends. This study will be of interest to the biotechnology and pharmaceutical industries and related life science, analytics, drug discovery, and diagnostic test manufacturing companies as well as all those interested or actively working in drug and imaging agent research and investors in all of the above.

To know more about kindly visit :

Related reports

The Blood Industry

Cord Blood, Embryonic and Adult Stem Cells Applications & Technologies - A Global Market Watch, 2009 - 2015



Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668 
Fax: +91 22 27579131
Follow us on twitter:!/BharatBook


Show HTML Embed Snippet

This release was submitted by a Newsbox user.
Any communication related to the content of this release should be sent to the release submitter.

Contact Info

From Name
From Email
From Company
Login to Submit Email

Author Info

Tag Cloud


More Releases


Add a Comment